Sunday August 20th 2017

Posts Tagged ‘advocacy’

Mixed Results from FDA Advisory Panel Meeting To Consider Marketing Approval of Lemtrada™ (alemtuzumab) for Relapsing MS

Mixed Results from FDA Advisory Panel Meeting To Consider Marketing Approval of Lemtrada™ (alemtuzumab) for Relapsing MS

An FDA advisory committee met to discuss the application for marketing approval of Lemtrada as a disease-modifying therapy for people with relapsing forms of MS. [Read More]

National MS Society Commits $19.4 Million in 38 New Research Projects

National MS Society Commits $19.4 Million in 38 New Research Projects

The National MS Society has just launched 38 new MS research projects, with multiyear commitments totaling $19.4 million. This commitment is the latest in the Society’s relentless research effort to find solutions for everyone affected by MS. [Read More]